Related Experiment Video
Updated: Oct 11, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
COVID-19, gender and estroprogestins, what do we know?
Tiziana Fidecicchi1, Franca Fruzzetti1, Luis Ignacio Lete Lasa2
1Department of Obstetrics and Gynecology, Pisa University Hospital of S. Chiara, Azienda Ospedaliera Universitaria, Pisa, Italy.
Women may have natural protection against severe COVID-19 due to female hormones, potentially explaining lower mortality. This review examines COVID-19 thrombosis mechanisms and hormonal therapy impacts.
Area of Science:
- Virology
- Immunology
- Endocrinology
Background:
- The COVID-19 pandemic presents challenges in understanding disease pathogenesis and treatment.
- A prothrombotic state is linked to COVID-19 mortality.
- Women exhibit lower susceptibility and mortality rates compared to men in COVID-19.
Purpose of the Study:
- To explore the mechanisms of thrombosis in COVID-19.
- To investigate potential reasons for natural protection in women against severe COVID-19.
- To review expert opinions on hormonal therapies and vaccine-related thrombosis.
Main Methods:
- Literature review of COVID-19 pathogenesis and thrombosis.
- Analysis of gender-based differences in COVID-19 severity and mortality.
- Discussion of hormonal influences on inflammation and thrombosis.
- Review of data on vaccine-induced immune thrombotic thrombocytopaenia.
Main Results:
- Female hormones may modulate inflammation, contributing to a protective effect in women.
- Hormone therapies are under scrutiny for potential increased risk of severe COVID-19.
- Rare thrombotic side effects of COVID-19 vaccines (VITT) warrant discussion.
Conclusions:
- Understanding the gender gap in COVID-19 severity is crucial.
- Further research is needed on hormone therapy management during the pandemic.
- Awareness and investigation of vaccine-related thrombosis are essential for public health.
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Disorders of the Female Reproductive System
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
Hormonal Regulation
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

